Hi bluebush
The paragraph that I like the best is this one..........Management remains confident that these confirmatory trials will support the conclusions of the Phase II trials that ArTiMist can provide a viable alternative to the commonly accepted treatment of intravenous I quinine.
We know that phase II trials were fine and given that management will have some raw data there is confidence underlying this statement.
kippax
- Forums
- ASX - By Stock
- EMS
- phase iii trials complete - data awaited
phase iii trials complete - data awaited, page-29
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist